NC
NGNE icon

Nexthera Capital’s Neurogene NGNE Stock Holding History

Nexthera Capital’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,535
Closed -$1.28M – 42
2017
Q2 		$1.28M Buy
+4,535
New +$1.3M 0.56% 32
2016
Q4 		– Sell
-17,000
Closed -$4.54M – 41
2016
Q3 		$4.54M Sell
17,000
-7,915
-32% -$1.6M 2.79% 10
2016
Q2 		$3.3M Buy
+24,915
New +$3.96M 2.86% 10

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nexthera Capital's NGNE Position: Q3 2017 in Review

Nexthera Capital sold out of Neurogene (NGNE) in Q3 2017, closing a stake of 4,535 shares — an estimated $1.28M sold.

Nexthera Capital first reported a position in NGNE in Q2 2016 and held it in 3 quarters. The position peaked at $4.54M in Q3 2016. 43 funds tracked by Wall St. Rank hold NGNE as of Q3 2017.

  • Nexthera Capital reported no remaining Neurogene position as of Q3 2017 after selling out during the quarter.
  • Nexthera Capital sold 4,535 Neurogene shares in Q3 2017, an estimated $1.28M.
  • Nexthera Capital first reported a position in Neurogene in Q2 2016 and held it in 3 quarters.
  • Nexthera Capital's Neurogene position peaked at $4.54M in Q3 2016.
  • 43 funds tracked by Wall St. Rank held Neurogene as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.